Less than six years after acquiring Cordis Corp. from Johnson & Johnson, Cardinal Health Inc. is selling the troubled cardiovascular device manufacturer to private equity firm Hellman & Friedman LLC for roughly $1 billion. Shares of the medical products and drugs distributor (NYSE:CAH) were up 2.93% to $57.35 at close on Friday.
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA announces recall of infusion sets; Recall announced for Roche testing systems; NIH announces technique for improved photoreceptor imaging.
Keeping you up to date on recent developments in neurology, including: Study finds graphene nanoparticles have positive influence on neurons; Packaging CRISPR/Cas9 components with nano-micelles enables brain genome editing; Five-year trends of Medicare payments for neurology drugs reported; Macrophages dampen neuropathic pain.
RSS
